Healthcare

X-Zell

Website
Founded 2014Origin source ↗Checked 2026-09-15

Overview

X-ZELL™ is a global start-up specialising in rare cell detection technology.

Backed by Y Combinator and various high-profile angel investors from around the globe – among them Gmail creator Paul Buchheit – X-ZELL™ has developed a world-first platform technology capable of isolating and visualizing rare and abnormal cells such as Circulating Endothelial Cells (CEC).

X-ZELL™’s platform technology is based on four core modules covering the entire spectrum from blood processing through to cell analysis and reporting – with every step performed in-house using patented and proprietary technology.

By combining the wisdom of 4,000 years of pathologic research with X-ZELL™’s own, cutting-edge technology,

X-ZELL™ ensures robust results and maximum clinical utility across a broad range of medical applications – from research through to medication management, companions diagnostics, relapse control and diagnostic decision-making.

More information on www.x-zell.com and @XZELLInc

Company description As recorded 2026-11-08
LinkedIn About
HealthcareHardware deviceBusinessesEnterpriseServices

Product & workflow

Products Overview Workflow IVDR Platform Reagents Cryophore Panels Antibodies & Conjugation OEM Manufacturing Next-Generation Cytology Cryosuite Platform Cell Culture Services

Source-reported As recorded 2026-09-23

Founders & team

Sebastian Punyaratabandhu Bhakdi

Founder

Sebastian started out as a physician at the University Hospital of Freiburg, Germany and earned a Degree in International Health at the Autonomous University of Barcelona, Spain, which made him realize that health services have to be accessible for all. A Research Fellowship from the German Research Foundation helped him to create his first patent which he used to found X-ZELL. He remains its CEO and Principal Investigator, growing the company to solve the world's cancer screening challenge.

LinkedIn
Founder profile As recorded 2026-09-15
19team members reported
Source-reported As recorded 2026-09-15

Founded 2014 · Source

News & product activity

Sources & observations

Y Combinator

Profile depthverified profile
Website observationwebsite reachable
Last website check2026-11-11
Location · source statedBangkok, Thailand; Düsseldorf, NRW, Germany
Pricing evidenceNo pricing page confirmed
Maturity: Not assessed · 3 of 6 areas documented

Source-based assessment · automated evidence rules

The retained text does not establish product availability or customer use.

Maturity is an evidence-based assessment, not a success rating. It may understate the current stage where evidence is limited. Coverage records documented areas, not a complete or independently audited company history.

Stage definitions
independent websitesource corroborationreachable websitedescriptive evidenceclassified market and modelsourced peoplesourced founding year
startup.observe Directory coverage · Sources & method